There are four names up for grabs this week looking to raise about $525 million as the IPO markets build steam following the government shutdown. Filings are up as well, which could be due to the fact that the government has only temporarily reopened, so companies are trying to get their paperwork reviewed before it shuts down again.
The first and largest offering of the week is California-based biotech Gossamer Bio (NASDAQ: GOSS), which will be offering 14.3 million shares at a price of $16. The company is focused on asthma and other treatments and hopes to raise $230 million. This early-stage biotech company will come to market with over a $1 billion valuation.
Continuing with the biotech stocks, the next largest offering is Alector (NASDAQ: ALEC), which is also based out of California. The company is focused on neurodegeneration therapies and is currently in Phase 1 clinical trials. They will offer 9.2 million shares at a range of $18 - $20 in hopes of raising $176 million.
The final biotech company up for grabs this week is Harpoon Therapeutics (NASDAQ: HARP), another Golden State venture. The company creates T cell-based medications to combat cancer. They're also in Phase 1 and will offer 5.4 million shares at a range of $13 -$15 in hopes of raising $76 million.
The last offering of the week is a small bank out of South Florida. BankFlorida (NYSE: BFL) is a community bank with only one branch in Southern Florida, which is looking for 4.2 million by offering $9.50 - $10.50.